Bacillus anthracis

From QMRAwiki
Revision as of 16:00, 14 September 2011 by Markweir (talk | contribs)
Jump to: navigation, search

Template:PSDS


Dose response models for Bacillus anthracis

Files

Hazard Identification

  1. Bravata, D. et al. (2007). Inhalational, Gastrointestinal, and Cutaneous Anthrax in Children. Archives of Pediatric & Adolescent Medicine, 161(9):896-905
  2. Holty, J. (2006) Systematic Review: A Century of Inhalational Anthrax Cases from 1900 to 2005. Annals of Internal Medicine, 144:270-280.
  3. Kostoff, R., Morse, S., and Oncu, S. (2007). The Seminal Literature of Anthrax Research. Critical Reviews in Microbiology, 33:171–181.
  4. Shepard C, Soriano-Gabarro M, Zell E, Hayslett J, Lukacs S, Goldstein S, Factor S, Jones J, Ridzon R, Williams I, and Rosenstein N. (2002). Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence. Emerging Infectious Diseases 8(10):1124-1132

Dose Response

Dose response models for Bacillus anthracis

  1. Haas, C.N. (2002). On the Risk of Mortality to Primates Exposed to Anthrax Spores. Risk Assessment, 22(2):189-193
  2. Weir, M. (2009). Development of Physiologically Based Pathogen Transport and Kinetics Model for Inhalation of Bacillus anthracis Spores

Dose Response Data

  1. Rhesus macaques exposed to 1 micron Bacillus anthracis spores

Exposure Assessment

  1. Adams, W. (2003) Measurement of Breathing Rate and Volume in Routinely Performed Daily Activities
  2. Herzog, A. et al. (2009). Implications of Limits of Detection of Various Methods for Bacillus anthracis in Computing Risks to Human Health. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, p. 6331–6339
  3. Hong, T., Gurian, P. (2009) Identifiability analysis for indoor air fate and transport model of Bacillus anthracis (Poster)
  4. Hong, T., Gurian, P., and Ward, N. (2009). Input-output Correlation Sensitivity Analysis for Environmental Standards for Bacillus Anthracis Spores. (Poster)
  5. National Center for Environmental Assessment. (1997). Exposure Factors Handbook

Risk Characterization

  1. Herzog, A. et al. (2008). Risk Assessment: Release of Anthrax in an IRS Building
  2. Fowler, R. et al. (2005).Cost-Effectiveness of Defending against Bioterrorism: A Comparison of Vaccination and Antibiotic Prophylaxis against Anthrax. Annals of Internal Medicine 142(8):601-611
  3. Hong, T. and Gurian, P. Key uncertainties in risk informed
  4. Hong, T. (2009). Estimating Risk of Exposure to Bacillus Anthracis based on Environmental Concentrations (thesis)